Publications by authors named "Jianlu Huang"

Article Synopsis
  • Dietary exposure to aflatoxin B1 (AFB1) induces mutations in the TP53 gene that are linked to liver cancer (HCC), especially in those also infected with hepatitis B virus (HBV).
  • A genome-wide association study identified SNPs associated with the TP53 R249S mutation, revealing that this mutation correlates with higher TP53 expression in HCC patients.
  • The study found significant links between specific SNPs (ADAMTS18, WDR49, and SLC8A3) and the R249S mutation, with variations in the ADAMTS18 gene expression observed between tumor and non-tumor tissues in HCC patients. *
View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is a worldwide malignancy with high morbidity and mortality. In this study, ubiquitin conjugating enzyme E2I (), a small ubiquitin-like modifier E2 enzyme reportedly expressed in tumors, was examined for its potential effects in HCC. Bioinformatics analysis was performed based on HCCDB, TIMER, and Kaplan-Meier plotter databases to explore the clinical implications in HCC.

View Article and Find Full Text PDF

Background: This study explored the prognostic significance of Glypican (GPC) family genes in patients with pancreatic ductal adenocarcinoma (PDAC) after pancreaticoduodenectomy using data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO).

Methods: A total of 112 PDAC patients from TCGA and 48 patients from GEO were included in the analysis. The relationship between overall survival and the expression of GPC family genes as well as basic clinical characteristics was analyzed using the Kaplan-Meier method with the log-rank test.

View Article and Find Full Text PDF
Article Synopsis
  • Hepatocellular carcinoma (HCC) is a challenging and deadly cancer with a high recurrence rate, making early diagnosis difficult.
  • This study investigates the long non-coding RNA DUXAP8 and its associated protein-coding genes (PCGs) to evaluate their potential as diagnostic and prognostic biomarkers for HCC using data from 370 patients.
  • The results revealed that DUXAP8 and specific PCGs have significant implications for diagnosis and prognosis, leading to a risk score model and identifying potential therapeutic drugs like cinchonine, bumetanide, and amiprilose.
View Article and Find Full Text PDF

: Hepatocellular carcinoma (HCC) has high morbidity and mortality and lacks effective biomarkers for early diagnosis and survival surveillance. Origin recognition complex (ORC), consisting of ORC1-6 isoforms, was examined to assess the potential significance of ORC isoforms for HCC prognosis. : Oncomine and Gene Expression Profiling Interactive Analysis (GEPIA) databases were used to examine differential isoform expression, stage-specific expression, calculate Pearson correlations and perform survival analysis.

View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is a lethal malignancy worldwide. HCC has traits of late diagnosis and high recurrence. This study explored potential diagnosis and prognosis significance of phospholipase C epsilon 1 (PLCE1) in HCC.

View Article and Find Full Text PDF

The goal of our current study is to assess the immunohistochemical of p53, p21, nm23, and VEGF expression in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) prognosis after hepatectomy, as well as the prospective molecular mechanisms of prognostic indicator. There were 419 HBV-related HCC patients who were from southern China of Guangxi province and were used to evaluate the immunohistochemical expression for these biomarkers in prognosis. A genome-wide expression microarray dataset of HBV-related HCC were obtained from GSE14520.

View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is one the most common malignancies and has poor prognosis in patients. The aim of the present study is to explore the clinical significance of the main genes involved in the Janus kinase (JAK)‑signal transducer and activator of transcription (STAT) pathway in HCC. GSE14520, a training cohort containing 212 hepatitis B virus‑infected HCC patients from the Gene Expression Omnibus database, and data from The Cancer Genome Atlas as a validation cohort containing 370 HCC patients, were used to analyze the diagnostic and prognostic significance for HCC.

View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is one of the leading causes of tumor‑related mortalities worldwide. Long noncoding RNAs have been reported to be associated with tumor initiation, progression and prognosis. The present study aimed to explore the association between long noncoding RNA LINC00668 and its co‑expression correlated protein‑coding genes (PCGs) in HCC.

View Article and Find Full Text PDF
Article Synopsis
  • * A study utilized computational biology and prognostic assessments to identify 915 overall survival (OS) and 480 recurrence-free survival (RFS)-related AS events in PDAC patients, aiming to find reliable predictive signatures.
  • * The findings revealed potential interactions between splicing factors and AS events, suggesting these could serve as new markers for predicting patient outcomes and targeting therapies for PDAC.
View Article and Find Full Text PDF

Background: Hepatocellular carcinoma (HCC) is among the most common and lethal malignancies worldwide. Apolipoproteins (APOs) have been reported increasingly for their relationships with tumors. We aim at exploring the potential relationships of apolipoprotein A (APOA) and apolipoprotein C (APOC) family members with HCC.

View Article and Find Full Text PDF

NM23 expression is closely associated with hepatocellular carcinoma (HCC) recurrence, but the hereditary factors influencing NM23 levels are unknown. Using public database, the diagnostic value of in HCC was investigated. A total of 424 hepatitis B virus- (HBV-) related HCC patients were enrolled to perform a genome-wide association study for identifying candidate variants associated with NM23 expression level.

View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is one of the most prevalent and life-threatening malignancies worldwide. There are few diagnostic and prognostic biomarkers and druggable targets for HCC. Aldehyde dehydrogenase 1 (ALDH1) is a marker of stem cells in a variety of cancers, but the mRNA levels and prognostic value of ALDH1 isoforms in HCC patients remain unknown.

View Article and Find Full Text PDF

Aldehyde dehydrogenase 1 family member L1 (ALDH1L1) is downregulated in hepatocellular carcinoma (HCC) tumors, and its decreased expression is associated with the poor prognosis of HCC patients. We, therefore, evaluated the effect of single nucleotide polymorphisms (SNPs) of ALDH1L1, and its mRNA expression on the survival of hepatitis B virus (HBV)‑related HCC patients and the association with tumor protein p53 (TP53) expression. ALDH1L1 SNPs in 415 HBV-related HCC patients were genotyped via direct sequencing.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the relationship between the expression of the MKI67 proliferation marker and gene variants in patients with Hepatocellular carcinoma (HCC) associated with hepatitis B virus (HBV).
  • Researchers analyzed data from 195 HCC patients and validated findings with 97 additional subjects, examining connections between MKI67, gene variants, and clinical outcomes.
  • Results showed that certain genetic variants near the TTN and CCDC8 genes are linked to MKI67 expression and could serve as potential biomarkers for predicting HCC patient prognosis.
View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies and a major cause of cancer involved death worldwide. Prognosis remains poor because of high recurrence rates and lack of effective relapse prevention strategies. Notch pathway plays an important role in tumor progression and metastasis, and it is associated with the prognosis of cancer.

View Article and Find Full Text PDF

Polymorphisms in the phospholipase C epsilon (PLCE) 1 gene play a crucial role in the development and progression of several types of cancer. The present study investigated the prognostic significance of PLCE1 gene polymorphisms and expression combined with serum α-fetoprotein (AFP) level in hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). Single nucleotide polymorphisms were genotyped by sequencing DNA isolated from surgically resected tumor samples of 421 HBV-related HCC patients, and expression profiles were generated based on the GSE14520 dataset.

View Article and Find Full Text PDF